By Tom Zanki ( December 10, 2015, 3:36 PM EST) -- Private-equity backed Swiss biotech Basilea Pharmaceutica Ltd. yanked its $190 million initial public offering, one of two life science companies to pull IPOs Wednesday due to weak market conditions, marking a mixed week for the once-sizzling sector that has also seen two companies price follow-ons totaling $345 million....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.